After years helping candidates break into the buy-side, I’ve noticed a pattern: the biggest career detours don’t come from bad interviews — they come from bad questions. * Questions that show you haven’t done your research (for the role a RESEARCH analyst) * Questions that show you don’t understand
Updated as of: 11/20/2025 Refund policy * Your first annual payment is non-refundable—no exceptions. * To avoid auto-renewal, my assistant will cancel your subscription after you sign-up. You'll retain access for one year from the payment date. * YOUR ANNUAL SUBSCRIPTION AUTO-RENEWS. Please cancel promptly if you don’
Causes and Implications for aspirants
In the 1970s, deep inside Goldman Sachs’ trading floor, a quiet revolution was taking place. It didn’t come from flashy IPOs or headline-grabbing deals, but from a small, intense corner of the firm known as the Risk Arbitrage Department — led by a former lawyer named Robert Rubin. Rubin wasn’
Biotech investing has a reputation for being exciting — and brutal. The upside is obvious: one big drug approval can send a stock up 50–100% in a single day. But the path there is littered with failure. Roughly 90% of drugs that enter clinical testing never make it to market.
In tech, people like to highlight “ex-Google” or “ex-Meta.” The buy-side works the same way. If you want to understand a fund, look at where the key person (the founders and the Director of Research, sometimes that’s the same person) came from. That usually gets you 80–90% of
Hedge funds fail all the time, yet they often slip beneath the radar of public awareness. It's only the colossal failures that grab the headlines. This is precisely the reason why deeply understanding what you are signing up for is paramount in building a long-term career in public
This idea occurred to me during one of my “wisdom walks”: Why not apply the 7 Power framework to the hedge fund industry? In this article, I will discuss how a hedge fund can successfully build moats in this ultra-competitive and fragile sector and what paths a start-up hedge fund
What is a multi-manager? A multi-manager ("MM") hedge fund is an investment firm consisting of many portfolio managers (PMs) managing portfolios autonomously. Each portfolio is referred to as a "pod", where PMs have complete discretion on how to construct their portfolio and have minimal interaction with
Before the proliferation of podcasts, hedge funds operated under a veil of secrecy. However, Coatue Management's insights into technology, media, and telecommunications (TMT) investing have been accessible for a long time thanks to Philippe Laffont and Chief Marketing Officer David Scully's teaching roles at MIT, Philippe’